As of June 21, 2025, Yantai Dongcheng Biochemicals Co Ltd (002675.SZ) reports a Current Ratio of 1.46.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Yantai Dongcheng Biochemicals Co Ltd's Current Ratio
Over recent years, Yantai Dongcheng Biochemicals Co Ltd's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 1.46 |
| 2023-12-31 | 1.27 |
| 2022-12-31 | 1.33 |
| 2021-12-31 | 1.42 |
| 2020-12-31 | 1.55 |
This gradual decrease highlights how Yantai Dongcheng Biochemicals Co Ltd manages its short-term assets and liabilities over time.
Comparing Yantai Dongcheng Biochemicals Co Ltd's Current Ratio to Peers
To better understand Yantai Dongcheng Biochemicals Co Ltd's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Yantai Dongcheng Biochemicals Co Ltd (002675.SZ) | 1.46 |
| Beijing Science Sun Pharmaceutical Co Ltd (300485.SZ) | 26.30 |
| Beijing Strong Biotechnologies Inc (300406.SZ) | 9.28 |
| Amoy Diagnostics Co Ltd (300685.SZ) | 9.18 |
| Beijing SL Pharmaceutical Co Ltd (002038.SZ) | 8.60 |
| Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336.SS) | 8.39 |
Compared to its competitors, Yantai Dongcheng Biochemicals Co Ltd's Current Ratio is among the lowest compared to peers, suggesting tighter liquidity management or potential short-term obligations concerns.